Henry Schein Market Cap 2010-2023 | HSIC

Henry Schein market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Henry Schein market cap as of April 26, 2024 is $9.36B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $9.356B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.953B 18.99
Becton Dickinson (BDX) United States $66.586B 19.34
West Pharmaceutical Services (WST) United States $26.953B 48.06
Cardinal Health (CAH) United States $25.250B 15.18
Align Technology (ALGN) United States $23.366B 45.13
Cooper (COO) United States $17.874B 27.05
Labcorp (LH) United States $16.686B 14.39
DENTSPLY SIRONA (XRAY) United States $6.293B 16.58
Merit Medical Systems (MMSI) United States $4.261B 24.38
Patterson (PDCO) United States $2.311B 11.07
STAAR Surgical (STAA) United States $2.304B 72.14
CONMED (CNMD) United States $1.906B 17.29
Atrion (ATRI) United States $0.702B 36.17
Lifevantage (LFVN) United States $0.080B 13.00
Pro-Dex (PDEX) United States $0.065B 24.61
Biolase (BIOL) United States $0.005B 0.00